Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:1421-1428
Published online before print May 1, 2008, doi: 10.1161/ATVBAHA.108.167197
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
28/8/1421    most recent
ATVBAHA.108.167197v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thorp, E.
Right arrow Articles by Tabas, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thorp, E.
Right arrow Articles by Tabas, I.
Related Collections
Right arrowRelated Article
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:1421.)
© 2008 American Heart Association, Inc.


Integrative Physiology/Experimental Medicine

Mertk Receptor Mutation Reduces Efferocytosis Efficiency and Promotes Apoptotic Cell Accumulation and Plaque Necrosis in Atherosclerotic Lesions of Apoe–/– Mice

Edward Thorp; Dongying Cui; Dorien M. Schrijvers; George Kuriakose; Ira Tabas

From the Departments of Medicine, Pathology & Cell Biology, and Physiology & Cellular Biophysics, Columbia University, New York.

Correspondence to Ira Tabas, MD, PhD, Department of Medicine, Columbia University, 630 West 168th Street, New York, NY 10032. E-mail iat1{at}columbia.edu

Objective— Atherosclerotic plaques that are prone to disruption and acute thrombotic vascular events are characterized by large necrotic cores. Necrotic cores result from the combination of macrophage apoptosis and defective phagocytic clearance (efferocytosis) of these apoptotic cells. We previously showed that macrophages with tyrosine kinase-defective Mertk receptor (MertkKD) have a defect in phagocytic clearance of apoptotic macrophages in vitro. Herein we test the hypothesis that the MertkKD mutation would result in increased accumulation of apoptotic cells and promote necrotic core expansion in a mouse model of advanced atherosclerosis.

Methods and Results— MertkKD;Apoe–/– mice and control Apoe–/– mice were fed a Western-type diet for 10 or 16 weeks, and aortic root lesions were analyzed for apoptosis and plaque necrosis. We found that the plaques of the MertkKD;Apoe–/– mice had a significant increase in terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL)-positive apoptotic cells. Most importantly, there were more non-macrophage-associated apoptotic cells in the MertkKD lesions, consistent with defective efferocytosis. The more advanced (16-week) MertkKD;Apoe–/– plaques were more necrotic, consistent with a progression from apoptotic cell accumulation to plaque necrosis in the setting of a defective efferocytosis receptor.

Conclusion— In a mouse model of advanced atherosclerosis, mutation of the phagocytic Mertk receptor promotes the accumulation of apoptotic cells and the formation of necrotic plaques. These data are consistent with the notion that a defect in an efferocytosis receptor can accelerate the progression of atherosclerosis and suggest a novel therapeutic target to prevent advanced plaque progression and its clinical consequences.


Key Words: atherosclerosis-pathophysiology • apoptosis • phagocytosis • animal models of human disease


Related Article:

Macrophage Function and Its Impact on Atherosclerotic Lesion Composition, Progression, and Stability: The Good, the Bad, and the Ugly
Jeffrey G. Dickhout, Sana Basseri, and Richard C. Austin
Arterioscler Thromb Vasc Biol 2008 28: 1413-1415. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Circ. Res.Home page
S. Li, Y. Sun, C.-P. Liang, E. B. Thorp, S. Han, A. W. Jehle, V. Saraswathi, B. Pridgen, J. E. Kanter, R. Li, et al.
Defective Phagocytosis of Apoptotic Cells by Macrophages in Atherosclerotic Lesions of ob/ob Mice and Reversal by a Fish Oil Diet
Circ. Res., November 20, 2009; 105(11): 1072 - 1082.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
E. Thorp and I. Tabas
Mechanisms and consequences of efferocytosis in advanced atherosclerosis
J. Leukoc. Biol., November 1, 2009; 86(5): 1089 - 1095.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
T. Seimon and I. Tabas
Mechanisms and consequences of macrophage apoptosis in atherosclerosis
J. Lipid Res., April 1, 2009; 50(Supplement): S382 - S387.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. C.H. Clarke and M. R. Bennett
Cause or Consequence: What Does Macrophage Apoptosis Do in Atherosclerosis?
Arterioscler Thromb Vasc Biol, February 1, 2009; 29(2): 153 - 155.
[Full Text] [PDF]


Home page
BloodHome page
D. Liao, X. Wang, M. Li, P. H. Lin, Q. Yao, and C. Chen
Human protein S inhibits the uptake of AcLDL and expression of SR-A through Mer receptor tyrosine kinase in human macrophages
Blood, January 1, 2009; 113(1): 165 - 174.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. G. Dickhout, S. Basseri, and R. C. Austin
Macrophage Function and Its Impact on Atherosclerotic Lesion Composition, Progression, and Stability: The Good, the Bad, and the Ugly
Arterioscler Thromb Vasc Biol, August 1, 2008; 28(8): 1413 - 1415.
[Full Text] [PDF]